Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Andrew Rech, MD, PhD

Parker Scholar

Biography

Andrew is a clinical pathology resident in the physician-scientist pathway at the University of Pennsylvania. Andrew researches basic and translational tumor immunology, using mouse models of cancer, patient tissue analysis, and systems approaches to improve immune therapy for cancer. In the past, Andrew has studied the immunobiology of radiation, regulatory T cells, tumor antigenicity, and resistance to immune checkpoint blockade.

Education & Training

  • 2009: Haverford College, BS, Biology
  • 2017: University of Pennsylvania, PhD, Cell and Molecular Biology
  • 2019: Perelman School of Medicine, University of Pennsylvania, MD

Awards & Honors

  • 2018-2019: Parker Scholar fellowship, Parker Institute for Cancer Immunotherapy
  • 2018 Mark L. Tykocinski, MD Award for Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania
  • 2009: Ariel G. Loewy Research Award in Biology
  • 2009: Innovation Award, Department of Pathology and Laboratory Medicine, University of Pennsylvania
  • 2007: Hurford Humanities Center Undergraduate Fellow